Innovative fluorescence-based diagnostic system identifies early-stage bladder cancer with 90% accuracy, utilizing untreated urine samples for at-home testing.

They incorporated urinary NMP22 levels, urine cytology, patient age and gender in their nomograms, which were internally validated and proved accuracy of over 80%. [18] Microsatellites are short ...